United States Pharmacopeia-India Pvt. Ltd., India
Dr. Ranjan Chakrabarti is currently Vice President – Biologics and Biotechnology at United States Pharmacopeial Convention at their India office. He has over 18 years of experience in Pharmaceutical and Biopharma industries. Before joining to Industry, he worked in Academics at SUNY, Buffalo and University of Massachusetts Medical Centre at USAand successfully coordinatedresearch projects in Cancer Cell Biology and Diabetes. He has guided several Ph. D. students. Dr. Ranjan was leading the Biology Group at Dr. Reddy’s Drug Discovery unit and was involved in discovering several clinical candidates, out licensing deals and leading collaborative projects with MNCs. He has also served at key management position in GVK Biosciences for both Drug Discovery services and collaborative Drug Discovery research. In this role, he has worked with several National and International Pharma and Biopharma companies for discovery and development of both chemical and biological molecules. Dr. Ranjan is the Co-Inventor of 32 US Patents, published 52 papers in peer reviewed International Journals and presented 57 lectures in International and National Conferences.
Quality Attributes of a Biologic product have the potential to impact pharmacological properties of a molecule including toxicity, safety and efficacy. Product Quality Attributes Can be categorized into 2 classifications – Critical Quality Attributes (CQA) and non-critical Quality Attributes. Commonly acknowledged CQAs for drug substance and product play an important role in standard setting process. United States Pharmacopeia (USP) is the oldest Pharmacopeia in the world involved in Standard setting process for both Chemical and Biological Medicines. Biological Standards work is guided by Expert Committees with members from different countries, whichin turn is supported by Expert Panels.The members of these committees and panels are from Manufacturers, International standard setting organization and government laboratories. USP is developing both vertical (monograph) and horizontal (general chapters) documentary standards in the area of Biologics supported by pharmacopeial reference standards. Standard setting process for Biologics is based on the Quality Attributes of the specific drugs. USP is developing standards in the area of Therapeutic Proteins and Vaccines. Several monographs and supporting General Chapters are being developed in these areas. Global reference standards to support these monographs are being developed in collaboration with NIBSC, UK.
Speaker PPTsDownload PPT